ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Avastin Approved To Treat Progressive Glioblastoma

May 29, 2009

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

Former BMS Executive Bodnar Indicted.

April 25, 2008

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005